Clinical Trial Update: GENetic Education Risk Assessment and TEsting Study [NA]

View source ↗

Summary

An active-not-recruiting clinical trial at Dana-Farber Cancer Institute evaluating genetic education, risk assessment, and testing for hereditary pancreatic can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Candidates for Hereditary Pancreatic Cancer Testing | NA | Status: ACTIVE_NOT_RECRUITING